Peer-reviewed veterinary case report
More regulatory T cells in blood of dogs with atopic dermatitis
By Hauck, Verena et al.·Published in Veterinary dermatology·2016·Clinic for Small Animal Internal Medicine·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Increased numbers of FoxP3-expressing CD4+ CD25+ regulatory T cells in peripheral blood from dogs with atopic dermatitis and its correlation with disease severity.
- Species:
- dog
Plain-English summary
A group of 35 dogs with atopic dermatitis (a chronic skin condition causing itching and inflammation) had higher levels of certain immune cells called regulatory T cells compared to 14 healthy dogs. These immune cells were found to be linked to the severity of the dogs' skin symptoms, meaning that as the number of these cells increased, so did the severity of the itching and skin issues. This suggests that these immune cells might play a role in how atopic dermatitis develops in dogs. More research is needed to fully understand their impact and how to better treat this condition.
People also search for: dog atopic dermatitis treatment · why is my dog itching · immune cells in dog skin disease · dog skin problems severity
Abstract
BACKGROUND: Atopic dermatitis (AD) is a common chronic inflammatory skin disease of humans and dogs. Regulatory T cells (Tregs) are essential controllers of immune homeostasis and have been shown to play a key role in human AD, even though frequencies of Tregs in atopic human patients vary greatly. Only two studies have reported Treg numbers in the peripheral blood of dogs with canine AD (CAD). OBJECTIVES: This study aimed to assess the numbers of circulating Tregs in healthy and atopic dogs, and to determine whether Treg numbers correlate with age, sex, disease severity or pre-treatment. ANIMALS: Client-owned dogs including 14 healthy dogs and 35 dogs with CAD. METHODS: Expression of Tregs in peripheral blood mononuclear cells was evaluated by flow cytometry. Tregs were phenotypically identified as T cells triple positive for CD4, CD25 and FoxP3. RESULTS: The percentage of circulating CD4(+)  CD25(+)  FoxP3(+) Tregs in atopic dogs was increased significantly compared to healthy dogs (mean 2.1% versus 1%, P = 0.002) and correlated with disease severity (Pruritus Scale: r = 0.48, P = 0.003; CADESI-04: r = 0.34, P = 0.044). No significant differences in age or sex were found in either group and pre-treatment had no influence on results for atopic dogs. CONCLUSIONS: Data suggest that, as in humans, CD4(+)  CD25(+)  FoxP3(+) Tregs may contribute to the pathogenesis of CAD as indicated by an association between Treg frequency and disease severity. Further investigation is required to improve the understanding of the role of Tregs in atopic dogs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/26748886/